Updates are available Correction dated 2020-10-01
Click to view Correction: https://doi.org/10.1038/s41467-020-18941-4
-
Authors
Martin, Paige B.
Kigoshi-Tansho, Yu
Sher, Roger B.
Ravenscroft, Gianina
Stauffer, Jennifer E.
Kumar, Rajesh
Yonashiro, Ryo
Müller, Tina
Griffith, Christopher
Allen, William
Pehlivan, Davut
Harel, Tamar
Zenker, Martin https://orcid.org/0000-0003-1618-9269
Howting, Denise
Schanze, Denny https://orcid.org/0000-0003-2748-9929
Faqeih, Eissa A.
Almontashiri, Naif A. M. https://orcid.org/0000-0003-3607-395X
Maroofian, Reza
Houlden, Henry https://orcid.org/0000-0002-2866-7777
Mazaheri, Neda
Galehdari, Hamid
Douglas, Ganka https://orcid.org/0000-0003-4113-6505
Posey, Jennifer E.
Ryan, Monique https://orcid.org/0000-0001-6397-1910
Lupski, James R.
Laing, Nigel G.
Joazeiro, Claudio A. P.
Cox, Gregory A.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS102414)
Amyotrophic Lateral Sclerosis Association (16-IIP-287)
- License Information
-
More Information
Article History
Received: 24 January 2020
Accepted: 11 August 2020
First Online: 15 September 2020
Change Date: 1 October 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: J.R.L. has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, Novartis, and is a co-inventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from genetic testing offered at Baylor Genetics (). J.R.L. serves on the Scientific Advisory Board of Baylor Genetics. G.D. is an employee of GeneDx, Inc. The remaining authors declare no competing interests.
